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ABSTRACT  
 
The thyrocytes are exposed to high levels of oxidative stress which could induce DNA damages. 
Base excision repair (BER) is one of the principal mechanisms of defense against oxidative DNA 
damage, however recent evidences suggest that also nucleotide excision repair (NER) could be 
involved. The aim of present work was to identify novel differentiated thyroid cancer (DTC) risk 
variants in BER and NER genes. For this purpose, the most strongly associated SNPs within NER 
and BER genes found in our previous GWAS on DTC were selected and replicated in an 
independent series of samples for a new case-control study. Although a positive signal was detected 
at the nominal level of 0.05 for rs7689099 (encoding for an aminoacid change proline to arginine at 
codon 117 within NEIL3), none of the considered SNPs (i.e. rs7990340 and rs690860 within RFC3, 
rs3744767 and rs1131636 within RPA1, rs16962916 and rs3136166 in ERCC4, and rs17739370 and 
rs7689099 in NEIL3) was associated with the risk of DTC when the correction of multiple testing 
was applied. In conclusion, a role of NER and BER pathways was evoked in the susceptibility to 
DTC. However, this seemed to be limited to few polymorphic genes and the overall effect size 
appeared weak.  
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1. INTRODUCTION 
Thyroid carcinoma (TC) is a rare tumor but it is the most frequent malignancy of the endocrine 
system. DTC is the most prevalent type [1] and its incidence is increasing worldwide [2]. Within 
DTC, the papillary type (PTC) is the most common, whereas the follicular type (FTC) is observed 
only in 5-10% of cases. During the biosynthesis of thyroid hormones a high quantity of hydrogen 
peroxide (H2O2) is generated on the apical membrane of thyrocytes by dual oxidase [3] and reactive 
oxygen species (ROS) are generated by NOX4 in the endoplasmic reticulum and nuclear membrane 
[4]. Thus, it is conceivable that thyrocytes are among the most exposed types of cells to oxidative 
stress. For example, Maier et al. (2006) showed that the rat thyroid gland has a high level of DNA 
oxidative damage in comparison with other tissues, such as liver, spleen, and lung [5]. This study 
also suggested that the tumor-initiating somatic mutations could be due to the oxidative 
microenvironment to which thyroid cells are subjected during their life. The carcinogenic effects of 
H2O2 on thyrocytes have been clearly demonstrated in different in vitro studies. When a rat thyroid 
cell line (PCCL3) was incubated with nonlethal H2O2 concentrations, the number of single- and 
double-strand breaks in DNA increased as did the phosphorylation of histone H2AX, a marker of 
double-strand breaks [6]. Moreover, H2O2 exposure induced RET/PTC rearrangements in human 
thyroid cell lines, which was suppressed when catalase was added to the incubation medium [7]. 
Thus, it could be hypothesized that the metabolic stress linked to thyroid hormones biosynthesis 
causes somatic mutations and, then, constitutes a risk factor for developing DTC in humans [8]. 
Base Excision Repair (BER) is one of the most important lines of defense against oxidative DNA 
damages in nucleus and mitochondria [9]. It removes oxidized bases producing a-basic sites and it 
has a role also in repairing single-strand breaks in DNA. However, cumulating evidences show that 
also Nucleotide Excision Repair (NER) could play a role [10]. Defects in Cockayne syndrome 
proteins A and B (CSA and CSB, respectively) are thought to cause an accumulation of ROS, 
thereby contributing to the premature aging phenotype of the disease [11]. Moreover, CSB-
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defective cell lines from rodents or patients appeared hypersensitive to ionizing radiations as well as 
various types of oxidative stress [12-14]. In addition, rodent Xp-C defective cells were more 
sensitive, in terms of survival and mutations’ accumulation, to ROS than wild-type cells [15]. 
Furthermore, studies using human primary keratinocytes and fibroblasts from XP-C patients 
showed that XPC protects human skin cells from the killing effects of oxidants and X-rays [16]. 
Finally, in normal human keratinocytes the down-regulation of XPC resulted in increased 
intracellular ROS levels and genomic oxidation [17].  
Previous studies suggested an association between DTC and SNPs within the NER genes ERCC2 
[18], CCNH, XPC, and ERCC5 [19]. Moreover, a meta-analysis has shown an association between 
DTC risk and rs25489 (G>A) within the BER gene XRCC1 [20]. However, the role played by 
polymorphisms within DNA repair genes in relation to the risk of DTC has not been fully 
evaluated. Positive signals within NER/BER genes in a Genome-Wide Association Study (GWAS) 
(carried out by our research group, [21]) did not exceed the stringent genome-wide statistical 
significance threshold, thus the results remained inconclusive (see suppl. table 1). In the present 
work we performed a hypothesis-driven study aimed to replicate the strongest associations of the 
GWAS with the goal of better defining whether polymorphic genes within NER and BER pathways 
could play a role in modulating the risk of DTC in humans. 
 
2. MATERIAL AND METHODS  
2.1 Study population 
Cases were DTC patients followed at the Department of Endocrinology of the University Hospital 
of Pisa, Italy. Controls were blood donors collected at Meyer Hospital of Florence (Italy) and 
healthy subjects working at the University Hospital of Pisa recruited during their routine visits in 
the context of a program of surveillance performed by the Occupational Medicine unit. In the 
present study, consecutively recruited 1,500 cases and 1,500 controls were collected with 
participation rates of about 95% and 85%, respectively. The genotyping for replicating the results of 
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the GWAS were carried out on the last consecutive 450 cases and 450 controls. The eligibility 
criteria were the same for cases and controls, and it included a minimal age of 18 years. Volunteers 
affected by any malignancy, chronic inflammatory disease, or related diseases in the past were 
excluded. A further exclusion criterion for controls was the presence of thyroid nodules or other 
benign thyroid diseases, when known. Both cases and controls should not have familial relationship 
with each other. All participants were of Caucasian origins. According to the Helsinki declaration, 
both healthy and affected volunteers gave their written informed consent to participate in the study 
and the study protocol was cleared by the local Ethical Committee. 
2.2 Candidate genes and SNPs selection 
In order to retrieve a list of genes coding for BER and NER involved proteins, three publicly 
available online databases were investigated: KEGG (Kyoto Encyclopedia of Genes and Genome, 
http://www.genome.jp/kegg), CGAP (Cancer Genome Anatomy Project, (http://cgap.nci.nih.gov) 
and Gene Ontology (http://www.geneontology.org). Among a broad list of 144 genes, 104 were 
described as belonging to these pathways in at least two databases and 979 SNPs, belonging to 
these latter genes, were analyzed in association with DTC in a GWAS performed by our research 
group [21]. For each gene a regional plot was generated using LocusZoom 
(http://csg.sph.umich.edu/locuszoom/). Genes with at least five haplotype-tagging SNPs (not in 
pair-wise linkage disequilibrium, r2<0.8, with each other) associated with the risk of DTC at allelic 
P-value level of 0.05 and minor allele frequency (MAF)>0.15 were selected and, for each of them, 
the two SNPs with the lowest allelic P-value were replicated (i.e. RFC3: rs7990340, rs690860; 
RPA1: rs3744767, rs1131636; ERCC4: rs16962916, rs3136166; NEIL3: rs17739370, rs7689099). 
2.3 DNA extraction and SNP genotyping 
DNA was extracted from peripheral blood samples otherwise disposed following the analyses of 
clinical routine. Puregene Blood Kit (Gentra Systems, Inc., Minneapolis, MN) was used for the 
extractions. Samples from cases and controls were randomized and mixed on PCR plates, so that an 
6 
 
equal number of cases and controls could be analyzed simultaneously by personnel blinded for the 
case/control status. Genotyping for all the SNPs was carried out using pre-designed TaqMan SNP 
Genotyping Assays, according to protocol specified by the manufacturer (Life Technologies Inc., 
Grand Island, New York, USA). Two percent of DNA samples were re-genotyped as quality 
control. 
2.4 Statistical analyses 
Hardy–Weinberg (H-W) equilibrium in controls was tested for each polymorphism by the Chi-
square (χ2) test. A logistic regression analysis was used to examine the associations between the 
genotypes and the considered risk factors. The association analyses were based on the estimation of 
the Odd Ratios (ORs) and of their 95% confidence intervals (CIs). Genotypes were analyzed with a 
multivariate logistic regression (MLR) model, allowing the ORs to be adjusted for covariates (age 
and sex) as linear variables (the ORadj). Each genotype category was compared using the common 
homozygotes as reference category and the P-value of the association (Pass) was calculated 
separately for heterozygotes and homozygotes. The False Discovery Rate (FDR) was employed to 
correct for multiple testing. The software Statgraphics Centurion (StatPoint Inc., USA) was used. 
2.5 Computational analyses 
To assess the possible functional role of each SNP in relation to putative cis-eQTL, we examined 
the eQTL dataset available for thyroid tissues within the GTEx Portal 
(http://www.gtexportal.org/home/). For in silico analysis of rs7689099, the functional effect on the 
encoded protein was evaluated with: Polyphen2 (http://genetics.bwh.harvard.edu/pph2/) [22], SIFT 
(PROVEAN) (http://sift.jcvi.org/), [23] and SNPs3D (http://www.snps3d.org/) [24].  
 
3. RESULTS   
3.1 Case-control association study  
7 
 
The characteristics of the population employed in the case-control association study are reported in 
table 1. The group of patients showed a higher proportion of females (OR=5.11; 95% CI=4.23-6.18, 
Pass<10
-6) and a lower average age when compared to controls (45.8 and 50.5 and, respectively, 
P<10-5). These covariates were taken into account in the MLR analysis, thus providing adequately 
adjusted ORs. Genotypes were in agreement with H-W equilibrium and passed the quality control 
(>99.5% of the re-analyzed samples confirmed their genotype). The results of the previous GWAS 
are summarized in figure 1, where top 13 genes were ranked using the SNPs with the lowest P-
association for each of them (the remaining genes are reported as supplementary table 1). The 
ORadj, the 95% CIs, and their Pass following MLR analysis of the additive, dominant, and recessive 
model are reported in table 2 for the replication study. The heterozygotes CT for rs1131636 within 
the 3’UTR of RPA1 were associated with a reduced risk of DTC (OR=0.73, 95% CI 0.54-0.98; 
Pass=0.04), but the homozygotes CC showed a risk very similar to the reference category (TT 
homozygotes) in the additive model, suggesting that the variant allele rs1131636-C is very unlikely 
associated with the  risk of DTC. 
However, two SNPs appeared to be statistically significant when using the classical threshold of 
0.05 as type-I error. TT homozygotes of rs17739370 within NEIL3 showed an increased risk of 
DTC: the OR was 1.76 (95% CI=1.13-2.72; Pass=0.01) when the common homozygotes CC were 
used as reference category in the additive model, or it was 1.92 (95% CI=1.07-2.43; Pass=0.02) 
when the CC+CT grouped genotypes were used as reference category in the recessive model. 
Moreover, GG homozygotes of rs7689099 within the coding region of NEIL3 showed a reduced 
risk of DTC in both the additive (OR=0.55, 95%CI=0.31-0.98; Pass=0.042) and recessive (OR=0.56, 
95%CI=0.31-1.00; Pass=0.05) models. However, after applying the FDR correction for multiple 
testing, none of the SNPs reached a statistical significance.  
 
3.2 Computational analysis 
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The genotyped polymorphisms were evaluated for their association with the mRNA expression 
levels (intended as quantitative trait loci, cis-eQTL) in 112 thyroid tissues available within GTex 
portal.  None of the SNPs was associated with a differential mRNA expression when the correction 
for multiple testing was applied. Moreover, rs7689099 within NEIL3 is a coding SNP causing the 
aminoacid change Pro>Arg at the codon 117 and this change was predicted by Polyphen2, SIFT 
(PROVEAN), and SNPs3D to affect the protein function. 
 
4. DISCUSSION 
GWAS promised to reveal common variants associated with disease risk. However, the initial 
enthusiasm was tempered by the fact that truly positive associations could be neglected once 
stringent thresholds of statistical significance at genome-wide level were applied, greatly reducing 
the power of these studies [25, 26]. Often, the effect of SNPs is too small to be individually detected 
[27] and an approach based on pathways could be more helpful to reveal positive signals hidden in 
the statistical noise. Following this reasoning, we screened all SNPs located in the NER and BER 
pathway genes for their association in our previous GWAS, under the hypothesis that DNA repair is 
very important in the defense of thyrocytes towards their own high level of oxidative stress. We 
selected the most strongly associated SNPs for the present replication study even though they did 
not reach the genome-wide statistical significance in the GWAS. The replication study failed to find 
statistically significant associations for the considered SNPs when a correction of multiple testing is 
applied. Thus, the results of the present study, together with the results obtained in the previous 
GWAS, suggest that NER and BER pathways are unlikely involved as important determinant in the 
predisposition to DTC. Overall, we are keen to conclude that if any effect of polymorphisms within 
NER and BER genes is present this should be very weak and difficult to be ascertained.  
However, it should be also noticed that the variant allele rs7689099, encoding for an aminoacid 
change Pro>Arg at codon 117 of NEIL3 showed an association with a reduced risk of DTC at the 
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nominal threshold level of 0.05. Moreover, the ORs in the replication study had the same direction 
of that found in the GWAS. Therefore, it cannot be ruled out that GWAS and replication study, 
separately, did not have enough statistical power to pinpoint weak associations.  
NEIL3 (endonuclease VIII-like 3) gene (within 4q34.3) encodes for a 605-amino acid Fpg/Nei-like 
DNA glycosylase [28-29], sharing homologies with other members of the same superfamily (i.e. 
NEIL1 and NEIL2) [30-33]. The protein has a role in the first step of BER by cleaving bases 
damaged by ROS and introducing an a-basic site [34]. While SNPs within NEIL1 and NEIL2 have 
already been evaluated in relation to different types of cancer [35-38], SNPs within NEIL3 have 
been poorly investigated. In one study, rs12645561 was associated with glioblastoma among 
Chinese [39] whereas rs7689099 was found associated with a reduced risk of prostate cancer among 
Caucasians [40], in agreement with the results obtained here for DTC. Theoretically, the aminoacid 
change Pro117Arg should affect the conformation of the protein and the activity, since proline, due 
to its cyclic structure, typically confers a reduced flexibility to the carbamidic bond and the in silico 
predictions seem to confirm this hypothesis. Thus, rs7689099 could be a functional polymorphism 
playing a role in several types of cancer, including TC. Future studies on large sample sets could be 
warranted for better ascertain the association of rs7689099 with the risk of DTC.  
 
 
Disclosure of Potential Conflicts of Interest 
No potential conflicts of interest were disclosed. 
Grant Support  
This work has received financial support from the Istituto Toscano Tumori and AIRC 
(Associazione Italiana Ricerca Cancro) that supported the study with an investigator grant (year 
2008).  
10 
 
References 
1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics, 
CA   Cancer J. Clin. 61 (2011) 69-90.  
2. E. Grande, J.J. Díez, C. Zafon, J.Capdevila, Thyroid cancer: molecular aspects and new 
therapeutic strategies, J. Thyroid Res. (2012) doi: 10.1155/2012/847108.  
3. U. Weyemi, B. Caillou, M. Talbot, R. Ameziane-El-Hassani, L. Lacroix, O. Lagent-
Chevallier, A. Al Ghuzlan, D. Roos, J.M. Bidart, A. Virion, M. Schlumberger, C. Dupuy, 
Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in 
normal and cancer thyroid tissues, Endocr. Relat.Cancer. 29 (2010) 27-37. 
4. D. Carvalho, C. Dupuy, Role of the NADPH Oxidases DUOX and NOX4 in Thyroid 
Oxidative Stress, Eur Thyroid J 2 (2013) 160–167. 
5. J. Maier, H. van Steeg, C. van Oostrom, S. Karger, R. Paschke, K. Krohn: 
Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats 
and mice, Endocrinology 147 (2006) 3391–3397. 
6. N. Driessens, S. Versteyhe, C. Ghaddhab, A. Burniat, X. De Deken, J. Van Sande, J.E. 
Dumont,  F. Miot, B. Corvilain,  Hydrogen peroxide induces DNA single- and double-
strand breaks  in thyroid cells and is therefore a potential mutagen for this organ, Endocr 
Relat Cancer (16) 2009 845–856. 
7. R. Ameziane-El-Hassani, M. Boufraqech, O. La-gente-Chevallier, U. Weyemi, M. Talbot, 
D. Métivier, F. Courtin, J.M. Bidart, M. El Mzibri, M. Schlumberger, C. Dupuy: Role of 
H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human 
thyroid cells, Cancer Res 70 (2010) 4123–4132. 
8. K. Krohn, J. Maier, R. Paschke, Mechanisms of disease: hydrogen peroxide, DNA 
damage and mutagenesis in the development of thyroid tumors, Nat Clin Pract Endocrinol 
Metab. 3 (2007) 713-20. 
11 
 
9. G. Slupphaug, B. Kavli, H.E. Krokan, The interacting pathways for prevention and repair 
of oxidative DNA damage, Mutat. Res. 531 (2003) 231-51. 
10. B. Pascucci, M. D'Errico, E. Parlanti, S. Giovannini, E. Dogliotti, Role of nucleotide 
excision repair proteins in oxidative DNA damage repair: an updating, Biochemistry 
(Mosc). 76 (2011) 4-15. 
11.  J. P. Melis, H. van Steeg, M. Luijten, Oxidative DNA Damage and Nucleotide Excision 
Repair Antioxid Redox Signal. 20 (2013) 2409-19. 
12. H. de Waard, J. de Wit, J.O. Andressoo, C.T. van Oostrom, B. Riis, A. Weimann, H.E. 
Poulsen, H. van Steeg, J.H. Hoeijmakers,  G.T. van der Horst, Different effects of CSA 
and CSB deficiency on sensitivity to oxidative DNA damage, Mol Cell Biol 24 (2004) 
7941–7948. 
13. H. de Waard, J. de Wit, T.G. Gorgels, G. van den Aardweg, J.O. Andressoo, M. Vermeij, 
H. van Steeg, J.H. Hoeijmakers, G.T. van der Horst. Cell type-specific hypersensitivity to 
oxidative damage in CSB and XPA mice. DNA Repair (Amst) 2 (2003) 13–25. 
14. G. Spivak, P.C. Hanawalt, Host cell reactivation of plasmids containing oxidative DNA 
lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome 
fibroblasts. DNA Repair (Amst) 5 (2006) 13–22. 
15. J.P. Melis, S.W. Wijnhoven, R.B. Beems, M. Roodbergen, J. van den Berg, H. Moon, E. 
Friedberg, G.T. van der Horst, J.H. Hoeijmakers, J. Vijg, H. van Steeg, Mouse models for 
xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer 
Res 68 (2008) 1347–1353. 
16. M. D’Errico, E. Parlanti, M. Teson, B.M. de Jesus, P. Degan, A. Cal-cagnile, P. Jaruga, 
M. Bjoras, M. Crescenzi, A.M. Pedrini, J.M. Egly, G. Zambruno, M. Stefanini, M. Di 
zdaroglu, E. Dogliotti. New functions of XPC in the protection of human skin cells from 
oxidative damage. EMBO J 25 (2006) 4305–4315. 
12 
 
17. H.R. Rezvani, R. Rossignol, N. Ali, G. Benard, X. Tang, H.S. Yang, T. Jouary, H. de 
Verneuil, A. Taieb, A.L. Kim, F. Mazurier. XPC silencing in normal human keratinocytes 
triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen 
species. 
Biochim Biophys Acta 1807 (2011) 609–619. 
18. S.N. Silva, O.M. Gil, V.C. Oliveira, M.N. Cabral, A.P. Azevedo, A. Faber, I. Manita, T.C. 
Ferreira, E. Limbert, J.E. Pina, J. Rueff, J. Gaspar, Association of polymorphisms in 
ERCC2 gene with non-familial thyroid cancer risk, Cancer Epidemiol. Biomarkers Prev. 
14 (2005) 2407-12. 
19. L.S. Santos, B.C. Gomes, R. Gouveia, S.N. Silva, A.P. Azevedo, V. Camacho, I. Manita, 
O.M. Gil, T.C. Ferreira, E. Limbert, J. Rueff, J.F. Gaspar, The role of CCNH Val270Ala 
(rs2230641) and other nucleotide excision repair polymorphisms in individual 
susceptibility to well-differentiated thyroid cancer, Oncol. Rep. 30 (2013) 2458-66. 
20. Y. Bao, L. Jiang, J.Y. Zhou, J.J. Zou, J.Y. Zheng, X.F. Chen, Z.M. Liu, Y.Q. Shi. XRCC1 
gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-
analysis of case-control studies, PLoS One. 22 (2013) e64851. 
21. A. Köhler, B. Chen, F. Gemignani, R. Elisei, C. Romei, G. Figlioli, M. Cipollini, A. 
Cristaudo, F. Bambi, P. Hoffmann, S. Herms, M. Kalemba, D. Kula, S. Harris, P. 
Broderick, R. Houlston, S. Pastor, R. Marcos, A. Velázquez, B. Jarzab, K. Hemminki, S. 
Landi, A. Försti. Genome-wide association study on differentiated thyroid cancer, J. Clin. 
Endocrinol. Metab. 98 (2013). doi: 10.1210/jc.2013-1941 
22. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. 
Kondrashov, S.R. Sunyaev, Nat. Methods 7 (2010) 248-249. 
23. P. Kumar, S. Henikoff, P.C. Ng, Predicting the effects of coding non-synonymous 
variants on protein function using the SIFT algorithm, Nat. Protoc. 4 (2009) 1073-81.  
13 
 
24.  P. Yue, E. Melamud, J. Moult, SNPs3D: candidate gene and SNP selection for 
association studies BMC Bioinformatics. 22 (2006) 166. 
25. F. Dudbridge, A. Gusnanto, Estimation of significance thresholds for genomewide 
association scans. Genet. Epidemiol. 32 (2008) 227–234. 
26. N. Risch, K. Merikangas, The future of genetic studies of complex human diseases. 
Science 273 (1996) 1516–1517 
27. C. Correia, Y. Diekmann, A.M. Vicente, JB Pereira-Leal, Hope for GWAS: relevant risk 
genes uncovered from GWAS statistical noise, Int J Mol Sci. 15 (2014) 17601-21. 
28. M. Takao, Y. Oohata, K. Kitadokoro, K. Kobayashi, S. Iwai, A. Yasui, S. Yonei, Q.M. 
Zhang, Human Nei-like protein NEIL3 has AP lyase activity specific for single-stranded 
DNA and confers oxidative stress resistance in Escherichia coli mutant. Genes Cells. 14 
(2009) 261-70 
29. M. Liu, V. Bandaru, A. Holmes, A.M. Averill, W. Cannan, S.S. Wallace. Expression and 
purification of active mouse and human NEIL3 proteins, Protein Expr. Purif. 84 (2012) 
130-9. 
30. M. Takao, S. Kanno, K. Kobayashi, Q.M. Zhang, S. Yonei, G.T. van der Horst, A. Yasui, 
A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) 
homologue, J Biol Chem. 277 (2002) 42205-13. 
31. V. Bandaru, S. Sunkara, S.S. Wallace, J.P. Bond, A novel human DNA glycosylase that 
removes oxidative DNA damage and is homologous to Escherichia coli endonuclease 
VIII, DNA Repair (Amst) 1 (2002) 517-29. 
32. I. Morland, V. Rolseth, L. Luna, T. Rognes, M. Bjørås, E. Seeberg, Human DNA 
glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair 
of 8-oxoguanine and other oxidation products in DNA, Nucleic Acids Res. 15 (2002) 
4926-36. 
14 
 
33. P. Jaruga, M. Birincioglu, T.A. Rosenquist, M. Dizdaroglu, Mouse NEIL1 protein is 
specific for excision of 2,6-diamino-4-hydroxy-5-formamidopyrimidine and 4,6-diamino-
5-formamidopyrimidine from oxidatively damaged DNA. Biochemistry. 21 (2004) 15909-
14. 
34. T.L. Scott, S. Rangaswamy, C.A. Wicker, T. Izumi, Repair of oxidative DNA damage and 
cancer: recent progress in DNA base excision repair. Antioxid Redox Signal. 20 (2014) 
708-26.  
35. H. Wei, A. Kamat, M. Chen, H.L. Ke, D.W. Chang, J. Yin, H.B. Grossman, C.P. Dinney, 
X. Wu, Association of polymorphisms in oxidative stress genes with clinical outcomes for 
bladder cancer treated with Bacillus Calmette-Guérin, PLoS One. 7 (2012) e38533. 
36. S. Dey, A.K. Maiti, M.L. Hegde, P.M. Hegde, I. Boldogh, P.S. Sarkar, S.Z. Abdel-
Rahman, A.H. Sarker, B. Hang, J. Xie, A.E. Tomkinson, M. Zhou, B. Shen, G. Wang, C. 
Wu, D. Yu, D. Lin, V. Cardenas, T.K. Hazra, Increased risk of lung cancer associated 
with a functionally impaired polymorphic variant of the human DNA glycosylase NEIL2. 
DNA Repair (Amst). 11 (2012) 570-8. 
37. M. Goto, K. Shinmura, H. Tao, S. Tsugane, H. Sugimura, Three novel NEIL1 promoter 
polymorphisms in gastric cancer patients, World J. Gastrointest. Oncol. 15 (2010) 117-20. 
38. X. Zhai, H. Zhao, Z. Liu, L.E. Wang, A.K. El-Naggar, E.M. Sturgis, Q. Wei, Functional 
variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell 
carcinoma of the oral cavity and oropharynx, Clin. Cancer Res. 14 (2008) 4345-52. 
39. T.B. Jin, X.L. Li, H. Yang, M. Jiri, X.G. Shi, D.Y. Yuan, L.L. Kang, S.Q. Li, Association 
of polymorphisms in FLT3, EGFR, ALOX5, and NEIL3 with glioblastoma in the Han 
Chinese population, Med. Oncol. 30 (2013) 718. 
40. K.H. Barry, S. Koutros, S.I. Berndt, G. Andreotti, J.A. Hoppin, D.P. Sandler, L.A. 
Burdette, M. Yeager, L.E. Freeman, J.H. Lubin, X. Ma, T. Zheng, M.C. Alavanja, Genetic 
15 
 
variation in base excision repair pathway genes, pesticide exposure, and prostate cancer 
risk, Environ. Health Perspect. 119 (2011) 1726-32. 
 
 
16 
 
Legend to supplementary table 1.  
An extract of the original PLINK file from previous genome-wide case-control association 
study on the risk of DTC (see reference [21]). Only the DNA repair genes considered in this 
study are showed, with the exception of the 13 genes displayed in figure 1. 
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Figure 1. The figure summarizes the most strongly associated 13 loci among 104 loci 
evaluated for NER and BER genes. Genes were ranked according to their most strongly 
associated SNP and the two most strongly associated SNPs for each of the first four genes 
were selected for replication. Dotted line shows the statistical threshold of 0.05. 
 
Table 1. Characteristics of DTC patients and controls. The OR and its 95% confidence interval 
(CI) were calculated with a logistic regression analysis. The difference between cases and 
controls for continuous variables was calculated with the student's t-test. 
 
 
aCrude Odd Ratio from logistic regression analysis.; b P-value from student's t-test. 
 
 
 Controls N(%) Cases N(%) ORa (95% CI) P-value 
Total 450 450   
Gender:     
Male 292 (64.8 %) 119 (26.5 %) Ref  
Female 158 (35.2 %) 331(73.5 %) 5.11 (4.23-6.18) <10-6 
Age (years) 
Average ± st.err. 
 
50.5±0.52 
 
45.8±0.49 
 
 
 
<10-5b 
Median 49.0 45.0   
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Table 2: Statistical analyses of 8 polymorphisms in BER and NER genes in the replication set. 
SNP Location Gene 
Risk 
Allele 
Risk allele 
frequency 
(cases) 
Risk allele 
frequency 
(controls) 
Additive (Het) 
OR (95% CI)b  
P-
value  
Additive (Hom) 
OR (95% CI)b 
P-
value  
Dominant OR 
(95% CI)b  
P-
value  
Recessive OR 
(95% CI)b  
P-
value  
rs7990340 flanking_3'-UTR RFC3 G 0.36 0.33 1.07 (0.80-1.43) 0.65 1.36 (0.87-2.13) 0.18 1.12 (0.86-1.48) 0.41 1.32 (0.86-2.1) 0.22 
rs690860 flanking_3'-UTR RFC3 C 0.43 0.44 0.84 (0.62-1.15) 0.27 1.01 (0.69-1.49) 0.96 0.89 (0.67-1.19) 0.43 1.12 (0.79-1.58) 0.52 
rs3744767 3’UTR RPA1 C 0.22 0.24 0.89 (0.67-1.19) 0.43 0.90 (0.48-1.70) 0.74 0.89 (0.68-1.17) 0.4 0.94 (0.50-1.76) 0.85 
rs1131636 3'-UTR RPA1 C 0.36 0.39 0.73 (0.54-0.98) 0.04 0.93 (0.61-1.41) 0.73 0.77 (0.58-1.01) 0.06 1.10 (0.74-1.62) 0.63 
rs16962916 flanking_5'-UTR ERCC4 C 0.27 0.27 1.09 (0.82-1.44) 0.55 0.90 (0.53-1.54) 0.12 1.06 (0.81-1.38) 0.67 0.87 (0.52-1.46) 0.6 
rs3136166 intron ERCC4 G 0.36 0.37 0.94 (0.73-1.20) 0.63 1.18 (0.84-1.65) 0.34 0.99 (0.79-1.25) 0.93 1.22 (089-1.67) 0.22 
rs17739370 flanking_3'-UTR NEIL3 T 0.38 0.33 1.16 (0.87-1.55) 0.31 1.76 (1.13-2.72) 0.01 1.27 (0.96-1.66) 0.09 1.62 (1.07-2.43) 0.02 
rs7689099 coding NEIL3 G 0.17 0.18 0.88 (0.71-1.09) 0.24 0.55 (0.31-0.98) 0.042 0.85 (0.69-1.05) 0.13 0.56 (0.31-1.00) 0.05 
   
b For each SNP, ORs adjusted for age and sex with corresponding 95% CIs and P values are shown. 
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